Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3D Global BiotechROCO:6808 -3.00%70 Days Inventory is 138.34 as of Dec. 2025, which is 247% above its 10-year median of 39.86. GuruFocus rates ROCO:6808 with a GF Score™ of 70/100 and a GF Value™ of NT$186.06 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 638 Biotechnology companies, 3D Global Biotech ranks better than 60.66% on this metric.
The historical rank and industry rank for 3D Global Biotech's Days Inventory or its related term are showing as below:
ROCO:6808'
s Days Inventory Range Over the Past 10 Years
Min: 2.38 Med: 39.86 Max: 139.84
Current: 139.84
During the past 9 years, 3D Global Biotech's highest Days Inventory was 139.84. The lowest was 2.38. And the median was 39.86.
ROCO:6808's Days Inventory is ranked better than 60.66% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs ROCO:6808: 139.84
3D Global Biotech's Days Inventory
increased
from Dec. 2024 (56.41) to Dec. 2025 (138.34).
It might indicate that 3D Global Biotech's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
3D Global Biotech's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.32.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
3D Global Biotech's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.29.
3D Global Biotech (ROCO:6808) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
3D Global Biotech's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
3D Global Biotech's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
3D Global Biotech Days Inventory Related Terms
3D Global Biotech Days Inventory Historical Data
* Premium members only.
The historical data trend for 3D Global Biotech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6808 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, 3D Global Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
3D Global Biotech Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 3D Global Biotech's Days Inventory distribution charts can be found below:
* The bar in red indicates where 3D Global Biotech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
3D Global Biotech (ROCO:6808) has a Days Inventory of 138.34 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on 3D Global Biotech and its competitors. This is 247% above median its historical median of 39.86. Over the past decade, 3D Global Biotech's Days Inventory has ranged from 2.38 to 139.84. According to the industry distribution chart, 3D Global Biotech ranks #251 out of 638 companies in the Biotechnology industry, placing it in the top 39.3%.
Is 3D Global Biotech's Days Inventory too high?
3D Global Biotech's current Days Inventory of 138.34 is 247% above median its 10-year median of 39.86. Over the past 10 years, this metric has ranged from a low of 2.38 to a high of 139.84. The Biotechnology industry median Days Inventory is 183.20. 3D Global Biotech's value of 138.34 is 24.5% below this industry median. Based on the distribution chart, 3D Global Biotech ranks #251 out of 638 companies in the Biotechnology industry, which is above the industry midpoint. Overall, 3D Global Biotech has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does 3D Global Biotech's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, 3D Global Biotech ranks #251 out of 638 companies for Days Inventory. This puts 3D Global Biotech in the upper half of its industry. The industry median Days Inventory is 183.20. 3D Global Biotech's value of 138.34 is 24.5% below this benchmark. Historically, 3D Global Biotech's own Days Inventory has ranged from 2.38 to 139.84 over the past decade. While the company's 10-year median is 39.86 vs. the industry median of 183.20, 3D Global Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 3D Global Biotech's current Days Inventory of 138.34 is 24.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on 3D Global Biotech and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 3D Global Biotech's current Days Inventory is 138.34, which is 247% above median its own 10-year median of 39.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3D Global Biotech stock overvalued right now?
Based on GuruFocus' analysis, 3D Global Biotech (ROCO:6808) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$186.06, compared to a current price of NT$38.85 — trading 79.1% below its estimated fair value. The current Days Inventory is 138.34, which is 247% above median its 10-year median of 39.86 and 24.5% below the Biotechnology industry median of 183.20. 3D Global Biotech's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For 3D Global Biotech (ROCO:6808), the current Days Inventory is 138.34 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 3D Global Biotech (ROCO:6808) Overvalued in 2026?
Based on GuruFocus' analysis, 3D Global Biotech stock appears to be undervalued.
The current stock price of NT$38.85 is trading 79.1% below its estimated GF Value™ of NT$186.06.
GuruFocus considers 3D Global Biotech to be Significantly Undervalued.
Key valuation signals for ROCO:6808:
Days Inventory: 138.34 (247% above median its 10-year median of 39.86)
GF Value™: NT$186.06 vs. price of NT$38.85 (79.1% below fair value)
Industry Position: 24.5% below the Biotechnology median (#251 of 638)
No single metric tells the full story. See the ROCO:6808 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
3D Global Biotech Inc is engaged in the research and development of high-end medical equipment and biological 3D printing technology and the sale of medical Materials and other related products.
70GF Score
Get the complete analysis for ROCO:6808
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6808 has been successfully added to your 
